Hainan Shuangcheng Pharmaceuticals (002693.SZ) terminates the issuance and acquisition of shares of Ningbo Aura Pharmaceuticals.

Hainan Shuangcheng Pharmaceuticals (002693.SZ) announced that the company had previously planned to purchase 100% of the shares of Ningbo Aura Semiconductor Co., Ltd. from 25 counterparties, including Hong Kong Aura Investment Co. Limited and Win Aiming Limited, by issuing shares and paying cash, and intended to issue shares to raise funds from up to 35 specific investors. Due to significant differences in the timing and cost at which each counterparty acquired shares of the target company, the parties had different expectations for the transaction. Despite multiple rounds of negotiations between the company and the counterparties, they were unable to reach a consensus on the commercial terms, including the transaction price. After careful consideration and thorough analysis, the company decided to terminate the issuance of shares, cash payment for asset acquisition, fundraising, and related party transactions.